Drawing for DDLD

USPTO serial 86734813

DDLD

Reviewed by CopyMark Law Group

Reg. 5202610Status 705Renewal
Filing date
Status date
Registration date
May 16, 2017
Examiner
KING, LINDA M
Law office
—

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with DDLD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cynthia A. Moyer

Cynthia A. Moyer Fredrikson & Byron, P.A.60 South Sixth StreetSuite 1500Minneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
035[ Inventory management services in the field of pharmaceuticals, namely, monitoring and managing the levels of stock of particular pharmaceutical products for third parties; wholesale distributorships featuring pharmaceutical products; wholesale distributorships featuring pharmaceutical products for use in clinical trials; business auditing services for pharmaceutical manufacturing companies; compilation of statistical data for use in scientific research; compilation of statistical data relating to medical research; provision of business statistical information relating to medical matters; procurement, namely, purchasing pharmaceutical products for others; computerized online ordering services for third parties in the field of pharmaceutical, veterinary and sanitary preparations and medical supplies; retail or wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies ]SECTION 8 - CANCELLED—
039Delivery of pharmaceutical products; storage of pharmaceutical products; warehousing of pharmaceutical products; distribution services, namely, delivery of pharmaceutical products; advisory services relating to the packaging of goods; advisory services relating to the repackaging of goods; advisory services relating to the storage of goods; bulk storage of goods; packaging articles for transportation; packaging articles to the order and specification of othersACTIVE—
042[ Testing, analysis and evaluation of the goods of others to determine conformity with certification standards in the field of pharmaceutical manufacturing; design of labels for others for use in clinical testing programs; conducting clinical trials for others in the field of pharmaceutical products; project management of clinical trials for others in the field of pharmaceutical products; product testing, authentication and quality control services for others in the field of clinical trials for pharmaceutical products; analytical scientific laboratory services; quality control for others; medical and scientific research, namely, conducting clinical trials for others; product testing for quality control; testing, analysis, and evaluation of pharmaceuticals to assure compliance with industry standards; inspection of pharmaceuticals; scientific laboratory services; product research and development services; testing, analysis and evaluation of the goods and services of others to determine conformity with certification standards; testing of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy pertaining to pharmacology; consultancy relating to scientific laboratory services; consultancy relating to scientific research and development in the field of therapeutics; development of pharmaceutical preparations and medicines; information technology consulting services for pharmaceutical and healthcare industries; laboratory research services relating to pharmaceuticals; medical laboratory services; medical research; pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the field of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of information relating to medical and veterinary product research and development; research and development of vaccines and medicines; scientific research in the field of pharmacy; pharmaceutical research services for assessing the efficiency of pharmaceuticals ]SECTION 8 - CANCELLED—
044[ Medical services; provision of advice in relation to the use of pharmaceutical products; advisory services relating to pharmaceuticals; consultancy and information services provided via the Internet relating to pharmaceutical products; consultancy and information services relating to pharmaceutical products; dispensing of pharmaceuticals; pharmaceutical advice; preparation and dispensing of medications; providing of information relating to the preparation and dispensing of medications; provision of information relating to medicine; provision of pharmaceutical information ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 16, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Apr 3, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Apr 3, 2024C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Apr 3, 2024EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Feb 16, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 16, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Feb 16, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 16, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 13, 2023PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
Nov 13, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 21, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 21, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 21, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 15, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Sep 1, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 1, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 1, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 16, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 16, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 30, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE—
Jan 26, 2017APETASSIGNED TO PETITION STAFF—
Dec 28, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 28, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 9, 2016EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Dec 5, 2016OTHECASE RETURNED TO EXAMINATION—
Dec 5, 2016IUCNNOTICE OF ALLOWANCE CANCELLED—
Jun 7, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 12, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 12, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 23, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 10, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 8, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Mar 7, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 7, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 7, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 1, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 1, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 24, 2016ALIEASSIGNED TO LIE—
Feb 17, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 14, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2015DOCKASSIGNED TO EXAMINER—
Aug 27, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 27, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance